Challenges with risk mitigation in academic drug discovery: finding the best solution
Author:
Affiliation:
1. High Throughput Screening laboratory, University of Kansas, Lawrence, KS, USA
Funder
NIGMS Chemical Biology of Infectious Disease grant
NCI Cancer Center Support grant
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1553952
Reference18 articles.
1. Early Probe and Drug Discovery in Academia: A Minireview
2. Academia–pharma partnerships for novel drug discovery: essential or nice to have?
3. NIH Molecular Libraries Initiative
4. Bringing together the academic drug discovery community
5. Contributions of Academic Laboratories to the Discovery and Development of Chemical Biology Tools
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immobilized cells on microcarriers for efficient and biomimetic screening of active compounds acting on FGFR4 from Fructus evodiae;Journal of Pharmaceutical and Biomedical Analysis;2024-09
2. DrugFinder: Druggable Protein Identification Model Based on Pre-Trained Models and Evolutionary Information;Algorithms;2023-05-25
3. Advancing drug repurposing research: Trends, collaborative networks, innovation and knowledge leaders;Drug Discovery Today;2022-12
4. RNA-binding proteins and cancer metastasis;Seminars in Cancer Biology;2022-11
5. Solvatochromic peptidic binder obtained via extended phage display acts as a fluororeporter for fragment-based drug discovery (FBDD);Analytical and Bioanalytical Chemistry;2022-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3